Essential Oil-based Personal Insect Repellent External Advisory Panel: Summary of Expertise, Experience, and Affiliations and Interests

The following information summarizes the expertise or experience, affiliations and interests relevant to the Essential Oil-based Personal Insect Repellent External Advisory Panel (EOPIR EAP) mandate declared by committee members. Health Canada considered these declarations as part of the selection process. This summary is available as part of Health Canada's commitment to be transparent about the membership of its advisory bodies.

Lists of Sectors, Expertise and Interests

Sector:

  • Research/Academia
  • Non-Governmental Organization

Expertise:

  • Toxicology
  • Non-Animal Approaches to Safety Assessment of Chemicals
  • Pharmacology
  • Pharmacognosy

1. Direct financial interests

  1. Current employment, investments in companies, partnerships, equity, royalties, joint ventures, trusts, real property, stocks, shares or bonds, with the regulated industry, of relevance to the EOPIR EAP mandate.

2. Indirect financial interests

  1. Within the past five years, payment from regulated industry for work done or being done, including past employment, contracts or consulting; or financial support including research support, personal education grants, contributions, fellowships, sponsorships, and honoraria, of relevance to the EOPIR EAP mandate.
  2. Within the past five years, materials, discounted products, gifts, or other benefits, or attendance at conferences or meetings where all or part of the travel and accommodation costs were provided by the regulated industry, of relevance to the EOPIR EAP mandate.
  3. Within the last three years, grants or other funding from the regulated industry, of relevance to the EOPIR EAP mandate, to any of the organizations where you are currently employed or participate in internal decision making.

3. Intellectual interests

  1. Within the last five years, any formal advice or opinion to industry; a Canadian federal, provincial or municipal government; a foreign government; or a non-government organization, on a matter of relevance to the EOPIR EAP mandate.
  2. Within the past five years, any published or publicly stated point of view, including speeches, lobbying, scientific papers, articles, journals, other publications, or Web sites, on issues of relevance to the EOPIR EAP mandate.
  3. Current professional or volunteer affiliations such as membership of professional/scientific societies, trade associations, lobbying, public interest or advocacy groups, that may have an interest in the mandate and work of the EOPIR EAP.

4. Other

  1. Any other affiliations and interests or potential circumstances that might give a well-informed member of the public reasonable apprehension or grounds for concern regarding the integrity and objectivity of your participation.

Summary of Responses from Members

Len Ritter (Chair)

Sector
Research/Academia
Expertise
Toxicology (Regulatory)
Summary of Responses
1a. No
2a. No
2b. No
2c. No
3a. No
3b. No
3c. No
4a. No
Comments
None

Barbara Hales

Sector
Research/Academia
Expertise
Toxicology (Developmental and Reproductive)
Pharmacology
Pharmacognosy
Summary of Responses
1a. No
2a. Yes
2b. Yes
2c. Yes
3a. Yes
3b. No
3c. No
4a. No
Comments
Dr. Hales has been a Consultant for Health Canada ($4,000; April 2010) and held Canadian Institutes of Health Research (CIHR) research grants as a principal investigator or co-applicant. Dr. Hales has also received payment for a CIHR workshop ($250; May 2013) and a speaker honorarium for a Teratology Society course in 2014 ($250).

Dr. Hales is a member of Society of Toxicology of Canada, Society of Toxicology, Teratology Society, Toxicological Sciences (Associate Editor), Birth Defects Research Part B (Editorial Board), American Society for Pharmacology and Experimental Therapeutics, Society for Developmental Biology, and Endocrine Society

Troy Seidle

Sector
Non-Governmental Organization
Expertise
Non-Animal Approaches to Safety Assessment of Chemicals
Toxicology (Regulatory)
Summary of Responses
1a. No
2a. Yes
2b. No
2c. No
3a. Yes
3b. Yes
3c. Yes
4a. No
Comments
Since 2006, Mr. Seidle has served as a consulting lobbyist to the animal welfare non-governmental organization Humane Society International with the broad mandate to promote the application of available and scientifically robust toxicological testing approaches to replace, reduce or refine the use of animals. In this capacity he has provided scientific and policy advice to EU institutions (Commission, Parliament and Member States), to the United States Environmental Protection Agency, and to the Brazilian Sanitary Surveillance Agency, regarding the revision of data requirements for pesticide chemicals and products.

Thomas E. Massey

Sector
Research/Academia
Expertise
Toxicology (Biochemical and Molecular)
Pharmacology
Summary of Responses
1a. No
2a. No
2b. No
2c. No
3a. No
3b. No
3c. No
4a. No
Comments
None

Valerie Assinewe

Sector
Non-Governmental Organization
Expertise
Toxicology
Pharmacology
Summary of Responses
1a. No
2a. Yes
2b. No
2c. No
3a. No
3b. No
3c. No
4a. No
Comments
Dr. Assinewe was a BI-03 and BI-04 employee of Health Canada in the Natural Health Products Directorate for almost 9 years.

Page details

Date modified: